Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 75

1.

Relationship between operator and hospital volumes and short-term mortality for percutaneous coronary intervention in New York.

Qian F, Zhong Y, Hannan EL.

Int J Cardiol. 2019 May 6. pii: S0167-5273(19)30028-2. doi: 10.1016/j.ijcard.2019.05.005. [Epub ahead of print]

PMID:
31104824
2.

Disparity in age at lung cancer diagnosis between current and former smokers.

Campling BG, Ye Z, Lai Y, Li L, Bar-Ad V, Werner-Wasik M, Lu B, Cowan SW, Evans NR, Chervoneva I, Wang C.

J Cancer Res Clin Oncol. 2019 May;145(5):1243-1251. doi: 10.1007/s00432-019-02875-6. Epub 2019 Mar 4.

PMID:
30830294
3.

Treatment of Coronary Artery Disease and Acute Myocardial Infarction in Hospitals With and Without On-Site Coronary Artery Bypass Graft Surgery.

Hannan EL, Zhong Y, Wu Y, Berger PB, Jacobs AK, Walford G, Venditti FJ, Ling FSK, Tamis-Holland J, King SB 3rd.

Circ Cardiovasc Interv. 2019 Jan;12(1):e007097. doi: 10.1161/CIRCINTERVENTIONS.118.007097.

PMID:
30616362
4.

Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.

Ye Z, Wang C, Wan S, Mu Z, Zhang Z, Abu-Khalaf MM, Fellin FM, Silver DP, Neupane M, Jaslow RJ, Bhattacharya S, Tsangaris TN, Chervoneva I, Berger A, Austin L, Palazzo JP, Myers RE, Pancholy N, Toorkey D, Yao K, Krall M, Li X, Chen X, Fu X, Xing J, Hou L, Wei Q, Li B, Cristofanilli M, Yang H.

Eur J Cancer. 2019 Jan;106:133-143. doi: 10.1016/j.ejca.2018.10.012. Epub 2018 Dec 4.

PMID:
30528798
5.

A Routine Laboratory Data-Based Model for Predicting Recurrence After Curative Resection of Stage II Colorectal Cancer.

Ye Z, Wang C, Guo L, Palazzo JP, Han Z, Lai Y, Jiang J, Posey JA, Mallick AB, Li B, Jiang L, Yang H.

J Natl Compr Canc Netw. 2018 Oct;16(10):1183-1192. doi: 10.6004/jnccn.2018.7048.

PMID:
30323088
6.

Ferritin level prospectively predicts hepatocarcinogenesis in patients with chronic hepatitis B virus infection.

Bian Z, Hann HW, Ye Z, Yin C, Wang Y, Fang W, Wan S, Wang C, Tao K.

Oncol Lett. 2018 Sep;16(3):3499-3508. doi: 10.3892/ol.2018.9099. Epub 2018 Jul 6.

7.

Complete vs Incomplete Revascularization During Percutaneous Coronary Intervention and Improved Survival-The Key Is Immortality-Reply.

Hannan EL, Zhong Y.

JAMA Cardiol. 2018 May 1;3(5):444-445. doi: 10.1001/jamacardio.2018.0271. No abstract available.

PMID:
29590283
8.

Association of Coronary Vessel Characteristics With Outcome in Patients With Percutaneous Coronary Interventions With Incomplete Revascularization.

Hannan EL, Zhong Y, Berger PB, Jacobs AK, Walford G, Ling FSK, Venditti FJ, King SB 3rd.

JAMA Cardiol. 2018 Feb 1;3(2):123-130. doi: 10.1001/jamacardio.2017.4787.

9.

Prognostic value of routine laboratory variables in prediction of breast cancer recurrence.

Zhu Z, Li L, Ye Z, Fu T, Du Y, Shi A, Wu D, Li K, Zhu Y, Wang C, Fan Z.

Sci Rep. 2017 Aug 15;7(1):8135. doi: 10.1038/s41598-017-08240-2.

10.

Prognostic values of cancer associated macrophage-like cells (CAML) enumeration in metastatic breast cancer.

Mu Z, Wang C, Ye Z, Rossi G, Sun C, Li L, Zhu Z, Yang H, Cristofanilli M.

Breast Cancer Res Treat. 2017 Oct;165(3):733-741. doi: 10.1007/s10549-017-4372-8. Epub 2017 Jul 7.

PMID:
28687903
11.

Four-year comparative effectiveness of bare-metal and everolimus-eluting stents in New York.

Qian F, Zhong Y, Hannan EL.

Catheter Cardiovasc Interv. 2018 Feb 15;91(3):417-424. doi: 10.1002/ccd.27144. Epub 2017 May 30.

PMID:
28557275
12.

Incomplete revascularization for percutaneous coronary interventions: Variation among operators, and association with operator and hospital characteristics.

Hannan EL, Zhong Y, Jacobs AK, Ling FSK, Berger PB, Walford G, Venditti FJ, King SB 3rd.

Am Heart J. 2017 Apr;186:118-126. doi: 10.1016/j.ahj.2017.01.015. Epub 2017 Feb 8.

PMID:
28454825
13.

Long-term comparative effectiveness of Endeavor zotarolimus-eluting and everolimus-eluting stents in New York.

Qian F, Zhong Y, Hannan EL.

Int J Cardiol. 2017 Aug 15;241:437-443. doi: 10.1016/j.ijcard.2017.03.095. Epub 2017 Mar 23.

14.

Prospective and longitudinal evaluations of telomere length of circulating DNA as a risk predictor of hepatocellular carcinoma in HBV patients.

Wan S, Hann HW, Ye Z, Hann RS, Lai Y, Wang C, Li L, Myers RE, Li B, Xing J, Yang H.

Carcinogenesis. 2017 Apr 1;38(4):439-446. doi: 10.1093/carcin/bgx021.

15.

Comparison of 5-year outcomes of paclitaxel-eluting and endeavor zotarolimus-eluting stents in New York.

Qian F, Zhong Y, Hannan EL.

Catheter Cardiovasc Interv. 2018 Jan 1;91(1):9-16. doi: 10.1002/ccd.27000. Epub 2017 Mar 17.

PMID:
28303630
16.

The Impact of Excluding Shock Patients on Hospital and Physician Risk-Adjusted Mortality Rates for Percutaneous Coronary Interventions: The Implications for Public Reporting.

Hannan EL, Zhong Y, Cozzens K, Gesten F, Friedrich M, Berger PB, Jacobs AK, Walford G, Ling FS, Venditti FJ, King SB 3rd.

JACC Cardiovasc Interv. 2017 Feb 13;10(3):224-231. doi: 10.1016/j.jcin.2016.10.040.

17.

A Phase I/II Study of the Investigational Drug Alisertib in Combination With Abiraterone and Prednisone for Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Abiraterone.

Lin J, Patel SA, Sama AR, Hoffman-Censits JH, Kennedy B, Kilpatrick D, Ye Z, Yang H, Mu Z, Leiby B, Lewis N, Cristofanilli M, Kelly WK.

Oncologist. 2016 Nov;21(11):1296-1297e. doi: 10.1634/theoncologist.2016-0297. Epub 2016 Oct 24.

18.

Long-term comparative effectiveness of paclitaxel-eluting and everolimus-eluting stents in New York.

Qian F, Zhong Y, Hannan EL.

Int J Cardiol. 2017 Jan 15;227:490-496. doi: 10.1016/j.ijcard.2016.10.116. Epub 2016 Nov 2.

PMID:
27836296
19.

Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer.

Wang C, Mu Z, Chervoneva I, Austin L, Ye Z, Rossi G, Palazzo JP, Sun C, Abu-Khalaf M, Myers RE, Zhu Z, Ba Y, Li B, Hou L, Cristofanilli M, Yang H.

Breast Cancer Res Treat. 2017 Jan;161(1):83-94. doi: 10.1007/s10549-016-4026-2. Epub 2016 Oct 22.

PMID:
27771841
20.

Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.

Mu Z, Benali-Furet N, Uzan G, Znaty A, Ye Z, Paolillo C, Wang C, Austin L, Rossi G, Fortina P, Yang H, Cristofanilli M.

Int J Mol Sci. 2016 Sep 30;17(10). pii: E1665.

Supplemental Content

Loading ...
Support Center